Point of Care Diagnostics Market by Product, End-User and Mode of Prescription - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • ID: 3773059
  • Report
  • Region: Global
  • 145 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • MORE
Point of Care Diagnostics Market by Kits Product (Glucose Monitoring, Infectious Disease Testing, Pregnancy And Fertility Testing, Hematology Testing, Cardiometabolic Monitoring, Urinalysis Testing, Coagulation Monitoring, Tumor Markers Testing, Cholesterol Test Strips, Drugs Of Abuse Testing, Fecal Occult Testing) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

The point of care tests refers to the diagnostic procedures which are conducted outside of the laboratories. Point of care diagnostic procedures are carried out by various point of care diagnostics devices which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases and pregnancy testing. In addition, cardiac markers, fecal occult blood tests and blood gases tests can also be performed by using point of care diagnostic devices.

The global point of care diagnostics market size is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. Rising prevalence of various chronic and infectious diseases such as cardiac diseases, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) play a pivotal role in the growth of the global point of care diagnostics market. Moreover, changes in life style patterns also cause several medical conditions, such as diabetes, hypertension, and obesity, which fuels demand for point of care diagnostic procedures for their diagnosis & monitoring. Stringent government regulations and reimbursement issues for the point of care devices may hamper the growth of the market.

The world point of care diagnostics market is segmented based on product, end user, mode of prescription and geography. Based on product, the world point of care diagnostics market is further segmented into glucose monitoring kits; infectious disease testing kits; pregnancy and fertility testing kits; hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, coagulation monitoring kits, tumor/cancer markers testing kits, cholesterol test strips, drugs of abuse testing kits, fecal occult testing kits and others (calcium assay kits and immunohistochemistry kits. The infectious disease testing kits are further categorized into hepatitis testing kits, HIV testing kits, respiratory infections testing kits, influenza testing kits, healthcare-associated infections (HAIs) testing kits, sexually-transmitted diseases (STDs) testing kits and others (topical diseases testing kits and nerve conduction study kits). The cardiometabolic monitoring kits segment is further sub-divided into cardiac markers kits, HbA1c testing kits, electrolytes testing kits and among others.

Based on end user, the world point of care diagnostics market is segmented into professional diagnostic centers, research laboratories, home and others (medical universities, not-for-profit organizations and nursing homes). The professional diagnostic centers segment is further categorized into hospitals/critical care centers, outpatient healthcare settings, and ambulatory care settings. Based on the mode of prescription, the world point of care diagnostics market is segmented into prescription-based point of care diagnostic devices and over-the-counter (OTC) based point of care diagnostic devices market. Geographically, the market is segmented across four major regions, such as North America, Europe, Asia-Pacific, and LAMEA.

The point of care diagnostics market report provides a comprehensive analysis of the below key players operating in this market.

Abbott Laboratories,
Siemens AG, F.
Hoffmann-La Roche Ltd.
Sinocare Inc.
Johnson & Johnson
Sysmex Corporation
Nova Biomedical
Danaher Corporation
Becton Dickinson and Company
BioMérieux SA
Bio-Rad Laboratories.

Key Benefits:

The study provides an in-depth analysis of the world point of care diagnostics industry with current trends and future estimations to elucidate the imminent investment pockets in the market.
The point of care diagnostics market report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the world point of care diagnostics market, by product, helps in understanding the various types of devices used in the diagnosis of various diseases.
Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
Key market players within the point of care diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global point of care diagnostics market.

Key market segments

The world point of care diagnostics market is segmented into product, end user, mode of prescription and geography.

MARKET BY PRODUCT

Glucose monitoring kits
Infectious disease testing kits
Hepatitis testing kits
HIV testing kits
Respiratory infections testing kits
Influenza testing kits
Healthcare-associated infections (HAIs) testing kits
Sexually-transmitted diseases (STDs) testing kits
Others
Pregnancy and fertility testing kits
Pregnancy testing kits
Fertility Testing Kits
Hematology testing kits
Cardiometabolic monitoring kits
Cardiac Markers Kits
HbA1c Testing Kits
Electrolytes Testing Kits
Others
Urinalysis Testing Kits
Coagulation Monitoring Kits
Tumor/Cancer Markers Testing Kits
Cholesterol Test Strips
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Others

MARKET BY END USER

Professional diagnostic centers
Hospitals/critical care centers
Outpatient healthcare Setting
Ambulatory care settings
Research laboratories
Home
Others (medical universities, not-for-profit organizations and among others)

MARKET BY MODE OF PRESCRIPTION

Prescription based point of care diagnostic devices
Over-the-counter (OTC) based point of care diagnostic devices

MARKET BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Brazil
UAE
Others
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • MORE
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Increasing prevalence of chronic and infectitous diseases
3.4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness
3.4.1.3 Technological Advancements and adoption of home-based point of care devices
3.4.1.4 Increasing healthcare expenditures worldwide

3.4.2 Restraints

3.4.2.1 Stringent regulatory requirements for the approval and commercialization of point of care diagnostic devices
3.4.2.2 Inadequate reimbursement policies for point of care diagnostic devices

3.4.3 Opportunities

3.4.3.1 Developing economies offer lucarative growth opportunities

CHAPTER 4 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT

4.1 Overview
4.2 Glucose monitoring kits

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Infectious diseases testing kits

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Hepatitis testing kits

4.3.4.1 Market size and forecast

4.3.5 HIV testing kits

4.3.5.1 Market size and forecast

4.3.6 Respiratory infections testing kits

4.3.6.1 Market size and forecast

4.3.7 Influenza testing kits

4.3.7.1 Market size and forecast

4.3.8 Healthcare-associated infections (HAIs) testing kits

4.3.8.1 Market size and forecast

4.3.9 Sexually-transmitted diseases (STDs) testing kits

4.3.9.1 Market size and forecast

4.3.10 Other infectious disease point of care testing kits

4.3.10.1 Market size and forecast

4.4 Pregnancy and fertility testing kits

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Pregnancy testing kits

4.4.4.1 Market size and forecast

4.4.5 Fertility testing kits

4.4.5.1 Market size and forecast

4.5 Hematology testing kits

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Cardiometabolic monitoring kits

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Cardiac markers test kits

4.6.4.1 Market size and forecast

4.6.5 HbA1c testing kits

4.6.5.1 Market size and forecast

4.6.6 Electrolytes and metabolites testing kits

4.6.6.1 Market size and forecast

4.7 Urinalysis testing devices

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast

4.8 Coagulation monitoring kits

4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast

4.9 Tumor or cancer markers testing devices

4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast

4.10 Cholesterol testing strips

4.10.1 Key market trends
4.10.2 Key growth factors and opportunities
4.10.3 Market size and forecast

4.11 Drugs of abuse testing kits

4.11.1 Key market trends
4.11.2 Key growth factors and opportunities
4.11.3 Market size and forecast

4.12 Fecal occult testing kits

4.12.1 Key market trends
4.12.2 Key growth factors and opportunities
4.12.3 Market size and forecast

4.13 Other point of care testing devices

4.13.1 Key market trends
4.13.1 Key growth factors and opportunities
4.13.2 Market size and forecast

CHAPTER 5 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast

5.2 Professional diagnostic centers

5.2.1 Market size and forecast
5.2.2 Hospitals/critical care centers

5.2.2.1 Market size and forecast

5.2.3 Outpatient healthcare settings

5.2.3.1 Market size and forecast

5.2.4 Ambulatory care settings

5.2.4.1 Market size and forecast

5.3 Research laboratories

5.3.1 Market size and forecast

5.4 Home

5.4.1 Market size and forecast

5.5 Others

5.5.1 Market size and forecast

CHAPTER 6 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION

6.1 Introduction
6.2 Prescription based testing devices

6.2.1 Market size and forecast

6.3 Over-the-counter (OTC) testing devices

6.3.1 Market size and forecast

CHAPTER 7 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S. market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany market size and forecast
7.3.5 France market size and forecast
7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Rest of Europe

7.3.9.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 India

7.4.6.1 Market size and forecast

7.4.7 Rest of Asia-Pacific

7.4.7.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 UAE

7.5.5.1 Market size and forecast

7.5.6 Rest of LAMEA

7.5.6.1 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 Abbott Laboratories

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments

8.2 Siemens AG

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments

8.3 F. Hoffmann-La Roche Ltd

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments

8.4 Sinocare Inc.

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments

8.5 Johnson & Johnson

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments

8.6 Sysmex Corporation

8.6.1 Company overview
8.6.2 Operating product categories
8.6.3 Business performance
8.6.4 Key strategic moves & developments

8.7 Nova Biomedical

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments

8.8 Danaher Corporation

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments

8.9 Becton Dickinson and Company

8.9.1 Company overview
8.9.2 Business performance
8.9.3 Key strategies and development

8.10 bioMrieux SA

8.10.1 Company overview
8.10.2 bioMerieux - COMPANY SNAPSHOT
8.10.3 Operating business segments
8.10.4 Business performance
8.10.5 Key strategic moves & developments

8.11 Bio-Rad Laboratories

8.11.1 Company overview
8.11.2 Operating business segments
8.11.3 Business performance
8.11.4 Key strategic moves & developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • MORE
The Global Point of Care Diagnostics Market research report . The global point of care diagnostics market size would reach $43,336 million by 2022 from $22,975 million in 2015, growing at a CAGR of 9.4% from 2016 to 2022. Glucose monitoring kit was the leading segment in 2015 and is expected to continue dominance throughout the forecast period. North America would continue its lead, accounting for more than two-fifths share of the global point of care diagnostics market in 2015.

Rising prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rise in health awareness around the world are the factors majorly driving the point of care diagnostics market growth. The technological advancements in point of care diagnostic devices, introduction of home-based point of care devices; and increase in healthcare expenditure also support the growth of the global point of care diagnostics market. However, stringent government regulations for the product approval and reimbursement issues for the point of care devices restrict the market growth.

In 2015, the glucose monitoring kit segment accounted for over 40% share of the point of care diagnostics industry. Increase in demand for point of care glucose monitoring kits for the management of diabetes, and increase in prevalence of diabetes with rise in geriatric population & changes in lifestyle are the major factors that attribute to the high growth of this market. The infectious disease testing kits is the fastest-growing segment and is projected to register a CAGR of 13.1% during the forecast period. This is due to the growth in demand for point of care diagnostics in the diagnosis of various infectious diseases, which include tuberculosis (TB), HIV, influenza, and others.

Hepatitis testing kits, HIV testing kits, respiratory infections testing kits, influenza testing kits are expected to be the major contributor in the growth of infectious disease testing kits market during analysis period. The hepatitis testing kits segment is expected to maintain its lead in the overall infectious disease testing kits market throughout the analysis period, primarily due to the increase in incidences of liver disease cases. Furthermore, the HIV testing kits is anticipated to exhibit the highest growth, with a CAGR of 14.5% during the forecast period. This is owing to various initiatives implemented by the healthcare organizations for the free check-up facilities around the world.

The prescription-based point of care diagnostics holds largest market share in the global point of care diagnostics market because the devices are frequently used in healthcare facilities and prescribed by healthcare professionals. However, OTC-based point of care diagnostics market is estimated to register fastest CAGR of 10.4% during the forecast period owing to increase in awareness about the innovative and advanced applications of at-home point of care diagnostics and introduction of portable and hand-held devices.

The professional diagnostic center segment controlled major share of the point of care diagnostics industry in 2015. This segment is expected to maintain its lead in the overall point of care diagnostics market throughout the analysis period, primarily because of rise in number of healthcare facilities around the world. Moreover, the demand for point of care diagnostic devices and increase inpatient flow has further boosted the market growth. Moreover, the home end user segment is anticipated to exhibit the highest growth, with a CAGR of 9.7% during the forecast period. This is owing to increase in adoption of at-home point of care diagnostics and rapid launch of innovative and advanced portable devices.

North America and Europe together accounted for nearly three-fourths share of point of care diagnostics industry in 2015, and is expected to maintain this lead throughout the forecast period. The growth in the point of care diagnostics market size in these regions is attributed to the increased adoption of advanced point of care diagnostic devices, rise in awareness about innovative and advanced applications of point of care diagnostic devices, and rapidly aging population coupled with increase in incidences of diabetes and liver diseases. However, Asia-Pacific is projected to be the fastest-growing region, registering a CAGR of 12.0% during the analysis period. Japan is the leader in the Asia-Pacific point of care diagnostics market. This is mainly due to the increase in awareness of innovative and advanced applications of POC testing devices.

Key Findings of the Point of Care Diagnostics Market:

In 2015, glucose monitoring kits was the leading segment of overall point of care diagnostics market revenue.
Infectious disease testing kits segment is expected to grow at a remarkable CAGR of 13.1%, owing to increased demand in the diagnosis of infectious diseases.
North America was the leading reginal POC devices market followed by Europe and Asia-Pacific in 2015.
Over-the-counter testing kits segment is projected to grow at a CAGR of 104% during analysis period.
Japan alone is the major shareholder in the Asia-Pacific region accounting for about one-third share of the Asia-Pacific point of care diagnostics market.
Asia-Pacific infectious diseases testing kits market is expected to grow at a CAGR o 14.1% during analysis period.

The key players in the point of care diagnostics industry are highly focused to expand their business operations in the fast-growing emerging countries with new product launches as the preferred strategy. The key players profiled in this report include Abbott Laboratories, Siemens AG, F. Hoffmann-La Roche Ltd., Sinocare Inc., Johnson & Johnson, Sysmex Corporation, Nova Biomedical, Danaher Corporation, Becton Dickinson and Company, bioMrieux SA, and Bio-Rad Laboratories.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Siemens AG F
  • Hoffmann-La Roche Ltd
  • Sinocare Inc
  • Johnson & Johnson
  • Sysmex Corporation
  • Nova Biomedical
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMérieux SA
  • Bio-Rad Laboratories
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll